(Q44891764)

7 December 2017

title

Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. (English)

1 reference

7 December 2017

0 references

3

1 reference

7 December 2017

7

1 reference

7 December 2017

David L Sigalet

1

1 reference

7 December 2017

Laurie E Wallace

2

1 reference

7 December 2017

Gary R Martin

4

1 reference

7 December 2017

Tatsuru Kaji

5

1 reference

7 December 2017

Hiroaki Tanaka

6

1 reference

7 December 2017

publication date

29 March 2007

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

7 December 2017

published in

1 reference

7 December 2017

volume

293

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

G211-21

1 reference

cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Modulation of specific intestinal epithelial progenitors by enteric neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Prostaglandin E2 activation of VIP secretomotor neurons in the guinea pig ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Biologic actions and therapeutic potential of the proglucagon-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Role of vasoactive intestinal peptide and inflammatory mediators in enteric neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Neuroimmune interactions in experimental colitis. An immunoelectron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Plurichemical transmission and chemical coding of neurons in the digestive tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

A VIP hybrid antagonist: from developmental neurobiology to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

In vitro and in vivo treatment of colon cancer by VIP antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Epithelial proliferation in response to gastrointestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Alterations in capsaicin-evoked electrolyte transport during the evolution of guinea pig TNBS ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

Structure, measurement, and secretion of human glucagon-like peptide-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00530.2006

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00530.2006

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w6lcyagg6vhpddan7vj2tscxi4

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_w6lcyagg6vhpddan7vj2tscxi4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w6lcyagg6vhpddan7vj2tscxi4

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/w6lcyagg6vhpddan7vj2tscxi4

1 reference